Relevant bibliographies by topics / Experimental Autoimmune Neuritis / Journal articles

Journal articles on the topic 'Experimental Autoimmune Neuritis'

To see the other types of publications on this topic, follow the link: Experimental Autoimmune Neuritis.
Author: Grafiati
Published: 4 June 2021
Last updated: 21 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Experimental Autoimmune Neuritis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Fujioka, Toshiki. "Experimental autoimmune neuritis." Clinical and Experimental Neuroimmunology 9, no. 2 (May 2018): 84–92. http://dx.doi.org/10.1111/cen3.12461.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kezuka, Takeshi, Yoshihiko Usui, and Hiroshi Goto. "Analysis of the Pathogenesis of Experimental Autoimmune Optic Neuritis." Journal of Biomedicine and Biotechnology 2011 (2011): 1–5. http://dx.doi.org/10.1155/2011/294046.

Full text
Abstract:
Optic neuritis associated with multiple sclerosis has a strong association with organ-specific autoimmune disease. The goal of our research is to establish an optimal organ-specific animal model to elucidate the pathogenetic mechanisms of the disease and to develop therapeutic strategies using the model. This paper is divided into five sections: (1) clinical picture of optic neuritis associated with multiple sclerosis, (2) elucidation of pathogenesis using animal models with inflammation in optic nerve and spinal cord, (3) clinical relevance of concurrent encephalomyelitis in optic neuritis model, (4) retinal damage in a concurrent multiple sclerosis and optic neuritis model, and (5) development of novel therapies using mouse optic neuritis model. Advanced therapies using biologicals have succeeded to control intractable optic neuritis in animal models. This may ultimately lead to prevention of vision loss within a short period from acute onset of optic neuritis in human. By conducting research flexibly, ready to switch from the bench to the bedside and from the bedside to the bench as the opportunity arises, this strategy may help to guide the research of optic neuritis in the right direction.
APA, Harvard, Vancouver, ISO, and other styles
3

Zhang, Cun‐Jin, Hui Zhai, Yaping Yan, Junwei Hao, Min‐Shu Li, Wei‐Na Jin, Ning Su, Timothy L. Vollmer, and Fu‐Dong Shi. "Glatiramer acetate ameliorates experimental autoimmune neuritis." Immunology & Cell Biology 92, no. 2 (November 26, 2013): 164–69. http://dx.doi.org/10.1038/icb.2013.81.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Calik, Michael W., Sahadev A. Shankarappa, and Evan B. Stubbs. "Forced-exercise attenuates experimental autoimmune neuritis." Neurochemistry International 61, no. 2 (July 2012): 141–45. http://dx.doi.org/10.1016/j.neuint.2012.04.023.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wang, N., J. Chapman, R. Rabinowitz, S. Viskin, M. Kafri, and A. D. Korczyn. "Autonomic dysfunction in experimental autoimmune neuritis:." Journal of the Neurological Sciences 184, no. 2 (March 2001): 183–88. http://dx.doi.org/10.1016/s0022-510x(01)00444-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Han, Fuyu, Bangwei Luo, Rongchen Shi, Changhao Han, Zhonghao Zhang, Jian Xiong, Man Jiang, and Zhiren Zhang. "Curcumin ameliorates rat experimental autoimmune neuritis." Journal of Neuroscience Research 92, no. 6 (January 31, 2014): 743–50. http://dx.doi.org/10.1002/jnr.23357.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Shin, Taekyun, Meejung Ahn, Changjong Moon, and Seungjoon Kim. "Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis." Anatomy & Cell Biology 45, no. 4 (2012): 215. http://dx.doi.org/10.5115/acb.2012.45.4.215.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gabriel, C. "Human immunoglobulin ameliorates rat experimental autoimmune neuritis." Brain 120, no. 9 (September 1, 1997): 1533–40. http://dx.doi.org/10.1093/brain/120.9.1533.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hughes, P. "Matrix metalloproteinase expression during experimental autoimmune neuritis." Brain 121, no. 3 (March 1, 1998): 481–94. http://dx.doi.org/10.1093/brain/121.3.481.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Korn, T. "Suppression of experimental autoimmune neuritis by leflunomide." Brain 124, no. 9 (September 1, 2001): 1791–802. http://dx.doi.org/10.1093/brain/124.9.1791.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Ramkalawan, Hhoonisha, Yu-Zhong Wang, Ameet Hurbungs, Yan-Fang Yang, Fa-Fa Tian, Wen-Bin Zhou, Jing Li, Huan Yang, Bo Xiao, and Wei Zhang. "Pioglitazone, PPARγ Agonist, Attenuates Experimental Autoimmune Neuritis." Inflammation 35, no. 4 (March 3, 2012): 1338–47. http://dx.doi.org/10.1007/s10753-012-9447-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Manogaran, Praveena, Christine Walker-Egger, Marijana Samardzija, Conny Waschkies, Christian Grimm, Markus Rudin, and Sven Schippling. "Exploring experimental autoimmune optic neuritis using multimodal imaging." NeuroImage 175 (July 2018): 327–39. http://dx.doi.org/10.1016/j.neuroimage.2018.04.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Zhang, Min, Ru-Tao Liu, Peng Zhang, Na Zhang, Chun-Lin Yang, Long-Tao Yue, Xiao-Li Li, et al. "Parthenolide inhibits the initiation of experimental autoimmune neuritis." Journal of Neuroimmunology 305 (April 2017): 154–61. http://dx.doi.org/10.1016/j.jneuroim.2017.02.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Kieseier, Bernd C., Kim Krivacic, Stefan Jung, Heidrun Pischel, Klaus V. Toyka, Richard M. Ransohoff, and Hans-Peter Hartung. "Sequential expression of chemokines in experimental autoimmune neuritis." Journal of Neuroimmunology 110, no. 1-2 (October 2000): 121–29. http://dx.doi.org/10.1016/s0165-5728(00)00323-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Felts, Paul A., Kenneth J. Smith, Norman A. Gregson, and Richard A. C. Hughes. "Brain-derived neurotrophic factor in experimental autoimmune neuritis." Journal of Neuroimmunology 124, no. 1-2 (March 2002): 62–69. http://dx.doi.org/10.1016/s0165-5728(02)00017-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Zhang, Z., Z. Y. Zhang, U. Fauser, and H. J. Schluesener. "Valproic acid attenuates inflammation in experimental autoimmune neuritis." Cellular and Molecular Life Sciences 65, no. 24 (October 27, 2008): 4055–65. http://dx.doi.org/10.1007/s00018-008-8521-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Zhu, Deng, Diab, Zwingenberger, Bakhiet, and Link. "Thalidomide Prolongs Experimental Autoimmune Neuritis in Lewis Rats." Scandinavian Journal of Immunology 48, no. 4 (October 1998): 397–402. http://dx.doi.org/10.1046/j.1365-3083.1998.00421.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Katzav, Aviva, Hofit Bina, Ramona Aronovich, and Joab Chapman. "Treatment for experimental autoimmune neuritis with clodronate (Bonefos)." Immunologic Research 56, no. 2-3 (April 12, 2013): 334–40. http://dx.doi.org/10.1007/s12026-013-8406-y.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Zielasek, J. "Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis." Journal of Neuroimmunology 58, no. 1 (April 1995): 81–88. http://dx.doi.org/10.1016/0165-5728(94)00192-q.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Bettelli, Estelle, Maria Pagany, Howard L. Weiner, Christopher Linington, Raymond A. Sobel, and Vijay K. Kuchroo. "Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis." Journal of Experimental Medicine 197, no. 9 (May 5, 2003): 1073–81. http://dx.doi.org/10.1084/jem.20021603.

Full text
Abstract:
Multiple sclerosis (MS) is considered to be an autoimmune disease of the central nervous system (CNS) that in many patients first presents clinically as optic neuritis. The relationship of optic neuritis to MS is not well understood. We have generated novel T cell receptor (TCR) transgenic mice specific for myelin oligodendrocyte glycoprotein (MOG). MOG-specific transgenic T cells are not deleted nor tolerized and are functionally competent. A large proportion (>30%) of MOG-specific TCR transgenic mice spontaneously develop isolated optic neuritis without any clinical nor histological evidence of experimental autoimmune encephalomyelitis (EAE). Optic neuritis without EAE could also be induced in these mice by sensitization with suboptimal doses of MOG. The predilection of these mice to develop optic neuritis is associated with higher expression of MOG in the optic nerve than in the spinal cord. These results demonstrate that clinical manifestations of CNS autoimmune disease will vary depending on the identity of the target autoantigen and that MOG-specific T cell responses are involved in the genesis of isolated optic neuritis.
APA, Harvard, Vancouver, ISO, and other styles
21

Chun, Bo Young, Jong-Heon Kim, Youn-Kwan Jung, Yoon Seok Choi, Gunwoo Kim, Tomoko Yonezawa, and Kyoungho Suk. "Protective Role of Limitrin in Experimental Autoimmune Optic Neuritis." Investigative Opthalmology & Visual Science 62, no. 9 (July 7, 2021): 8. http://dx.doi.org/10.1167/iovs.62.9.8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Keino, Hiroshi, Takayo Watanabe, Yasuhiko Sato, Koichi Shudo, Yasushi Kitaoka, Takayuki Harada, and Annabelle A. Okada. "Retinoic acid receptor stimulation ameliorates experimental autoimmune optic neuritis." Clinical & Experimental Ophthalmology 43, no. 6 (April 22, 2014): 558–67. http://dx.doi.org/10.1111/ceo.12308.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Yan, Weixing, Toan Nguyen, Nobuhiro Yuki, Qiuhong Ji, Con Yiannikas, John D. Pollard, and Emily K. Mathey. "Antibodies to neurofascin exacerbate adoptive transfer experimental autoimmune neuritis." Journal of Neuroimmunology 277, no. 1-2 (December 2014): 13–17. http://dx.doi.org/10.1016/j.jneuroim.2014.09.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Moriguchi, Kota, Katsuichi Miyamoto, and Susumu Kusunoki. "4-Aminopyridine ameliorates experimental autoimmune neuritis in Lewis rats." Journal of Neuroimmunology 305 (April 2017): 72–74. http://dx.doi.org/10.1016/j.jneuroim.2017.01.023.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Muke, Ines, Alina Sprenger, Ilja Bobylev, Valerie Wiemer, Mohammed Barham, Wolfram Friedrich Neiss, and Helmar Christoph Lehmann. "Ultrastructural characterization of mitochondrial damage in experimental autoimmune neuritis." Journal of Neuroimmunology 343 (June 2020): 577218. http://dx.doi.org/10.1016/j.jneuroim.2020.577218.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Laurà, M., N. A. Gregson, Y. Curmi, and R. A. C. Hughes. "Efficacy of leukemia inhibitory factor in experimental autoimmune neuritis." Journal of Neuroimmunology 133, no. 1-2 (December 2002): 56–59. http://dx.doi.org/10.1016/s0165-5728(02)00359-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Constantinescu, Cris S., Brendan Hilliard, Ehud Lavi, Elvira Ventura, Vijay Venkatesh, and Abdolmohamad Rostami. "Suppression of experimental autoimmune neuritis by phosphodiesterase inhibitor pentoxifylline." Journal of the Neurological Sciences 143, no. 1-2 (November 1996): 14–18. http://dx.doi.org/10.1016/s0022-510x(96)00195-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Zhang, Zhi-Yuan, Zhiren Zhang, Caroline Zug, Barbara Nuesslein-Hildesheim, David Leppert, and Hermann J. Schluesener. "AUY954, a selective S1P1 modulator, prevents experimental autoimmune neuritis." Journal of Neuroimmunology 216, no. 1-2 (November 30, 2009): 59–65. http://dx.doi.org/10.1016/j.jneuroim.2009.09.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Lin, Hsin Hsin, Judith M. Spies, Jun Lan Lu, and John D. Pollard. "Effective treatment of experimental autoimmune neuritis with human immunoglobulin." Journal of the Neurological Sciences 256, no. 1-2 (May 2007): 61–67. http://dx.doi.org/10.1016/j.jns.2007.02.017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Karpati, T. "Inhibition of experimental autoimmune neuritis by the immunomodulator linomide." Immunology Letters 63, no. 3 (October 1998): 141–45. http://dx.doi.org/10.1016/s0165-2478(98)00070-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Yi, Chenju, Zhiyuan Zhang, Wei Wang, Caroline Zug, Hermann J. Schluesener, and Zhiren Zhang. "Doxycycline Attenuates Peripheral Inflammation in Rat Experimental Autoimmune Neuritis." Neurochemical Research 36, no. 11 (June 8, 2011): 1984–90. http://dx.doi.org/10.1007/s11064-011-0522-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Laura, M., N. A. Gregson, K. Smith, and R. A. C. Hughes. "Efficacy of leukaemia inhibitory factor in experimental autoimmune neuritis." Neuropathology and Applied Neurobiology 28, no. 2 (March 2002): 169. http://dx.doi.org/10.1046/j.1365-2990.2002.39286_56.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Shin, Hang-Cheol, Barbara Stuart, and Ernest F. McFarlane. "Conformation of an Antigenic Determinant for Experimental Autoimmune Neuritis." Biochemical and Biophysical Research Communications 224, no. 1 (July 1996): 5–9. http://dx.doi.org/10.1006/bbrc.1996.0975.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Gabriel, C. "Induction of experimental autoimmune neuritis with peripheral myelin protein-22." Brain 121, no. 10 (October 1, 1998): 1895–902. http://dx.doi.org/10.1093/brain/121.10.1895.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Wang, Shu-Xia, Chun-Lin Yang, Min Zhang, Peng Zhang, Ru-Tao Liu, Na Zhang, Bing Yang, Xiao-Li Li, Ying-Chun Dou, and Rui-Sheng Duan. "Sulfatides ameliorate experimental autoimmune neuritis by suppressing Th1/Th17 cells." Journal of Neuroimmunology 326 (January 2019): 55–61. http://dx.doi.org/10.1016/j.jneuroim.2018.11.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Xiao, J., H. Zhai, Y. Yao, C. Wang, W. Jiang, C. Zhang, A. R. Simard, R. Zhang, and J. Hao. "Chrysin attenuates experimental autoimmune neuritis by suppressing immuno-inflammatory responses." Neuroscience 262 (March 2014): 156–64. http://dx.doi.org/10.1016/j.neuroscience.2014.01.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Kafri, Michal, Yoel Kloog, Amos D. Korczyn, Ramona Ferdman-Aronovich, Vivian Drory, Aviva Katzav, Itzhak Wirguin, and Joab Chapman. "Inhibition of Ras attenuates the course of experimental autoimmune neuritis." Journal of Neuroimmunology 168, no. 1-2 (November 2005): 46–55. http://dx.doi.org/10.1016/j.jneuroim.2005.07.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Tan, Xiao-Dong, Ying-Chun Dou, Chang-Wen Shi, Rui-Sheng Duan, and Ruo-Peng Sun. "Administration of dehydroepiandrosterone ameliorates experimental autoimmune neuritis in Lewis rats." Journal of Neuroimmunology 207, no. 1-2 (February 2009): 39–44. http://dx.doi.org/10.1016/j.jneuroim.2008.11.011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Guo, Xiaoli, Chikako Harada, Kazuhiko Namekata, Kenji Kikushima, Yoshinori Mitamura, Hiroshi Yoshida, Yoh Matsumoto, and Takayuki Harada. "Effect of geranylgeranylacetone on optic neuritis in experimental autoimmune encephalomyelitis." Neuroscience Letters 462, no. 3 (September 2009): 281–85. http://dx.doi.org/10.1016/j.neulet.2009.07.028.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Matsunaga, Yoshimichi, Takeshi Kezuka, Xiaoming An, Kouji Fujita, Nagahisa Matsuyama, Ryusaku Matsuda, Yoshihiko Usui, Naoyuki Yamakawa, Masahiko Kuroda, and Hiroshi Goto. "Visual Functional and Histopathological Correlation in Experimental Autoimmune Optic Neuritis." Investigative Opthalmology & Visual Science 53, no. 11 (October 9, 2012): 6964. http://dx.doi.org/10.1167/iovs.12-10559.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Zhu, Wei, Eilhard Mix, Inger Nennesmo, Abdu Adem, and Jie Zhu. "Anti-cytokine autoantibodies in experimental autoimmune neuritis in Lewis rats." Experimental Neurology 190, no. 2 (December 2004): 486–94. http://dx.doi.org/10.1016/j.expneurol.2004.08.017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Gregorian, Shahik K., Wyne P. Lee, L. Steven Beck, Abdolmohamad Rostami, and Edward P. Amento. "Regulation of Experimental Autoimmune Neuritis by Transforming Growth Factor-β1." Cellular Immunology 156, no. 1 (June 1994): 102–12. http://dx.doi.org/10.1006/cimm.1994.1156.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Miyamoto, Katsuichi, Nobuyuki Oka, Teruaki Kawasaki, Sachiko Miyake, Takashi Yamamura, and Ichiro Akiguchi. "New cyclooxygenase-2 inhibitors for treatment of experimental autoimmune neuritis." Muscle & Nerve 25, no. 2 (January 28, 2002): 280–82. http://dx.doi.org/10.1002/mus.10019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Khan, Reas S., Kimberly Dine, John G. Geisler, and Kenneth S. Shindler. "Mitochondrial Uncoupler Prodrug of 2,4-Dinitrophenol, MP201, Prevents Neuronal Damage and Preserves Vision in Experimental Optic Neuritis." Oxidative Medicine and Cellular Longevity 2017 (2017): 1–10. http://dx.doi.org/10.1155/2017/7180632.

Full text
Abstract:
The ability of novel mitochondrial uncoupler prodrug of 2,4-dinitrophenol (DNP), MP201, to prevent neuronal damage and preserve visual function in an experimental autoimmune encephalomyelitis (EAE) model of optic neuritis was evaluated. Optic nerve inflammation, demyelination, and axonal loss are prominent features of optic neuritis, an inflammatory optic neuropathy often associated with the central nervous system demyelinating disease multiple sclerosis. Currently, optic neuritis is frequently treated with high-dose corticosteroids, but treatment fails to prevent permanent neuronal damage and associated vision changes that occur as optic neuritis resolves, thus suggesting that additional therapies are required. MP201 administered orally, once per day, attenuated visual dysfunction, preserved retinal ganglion cells (RGCs), and reduced RGC axonal loss and demyelination in the optic nerves of EAE mice, with limited effects on inflammation. The prominent mild mitochondrial uncoupling properties of MP201, with slow elimination of DNP, may contribute to the neuroprotective effect by modulating the entire mitochondria’s physiology directly. Results suggest that MP201 is a potential novel treatment for optic neuritis.
APA, Harvard, Vancouver, ISO, and other styles
45

Ciric, Bogoljub, Tarik Touil, Anjali Gupta, Kenneth Shindler, and Abdolmohamad Rostami. "The protease inhibitor, Bowman-Birk inhibitor, suppresses experimental autoimmune encephalomyelitis (131.33)." Journal of Immunology 178, no. 1_Supplement (April 1, 2007): S244. http://dx.doi.org/10.4049/jimmunol.178.supp.131.33.

Full text
Abstract:
Abstract The Bowman-Birk inhibitor (BBI) is a soybean-derived serine protease inhibitor. BBI concentrate (BBIC) is enriched with BBI, but is predominantly made up of other ingredients. In our previous study we found that oral administration of BBIC to Lewis rats with EAE resulted in significant clinical and histological suppression of disease. In the present study we investigated the effect of BBI using mouse EAE models and pure BBI. We found that both I.P. and oral treatment with BBI (typically 1 mg/day BBI) in SJL/PLP139–151, or C57BL/6/MOG35–55 models, significantly improved clinical and histological parameters of EAE (disease onset, severity, weight loss, inflammation and demyelination). This was true for different treatment regimens as regards the day of treatment initiation relative to immunization for EAE induction. In most experiments antigen-specific proliferation of immune cells derived from BBI-treated mice was significantly lower relative to control groups. In the SJL model of optic neuritis BBI significantly reduced the incidence of neuritis, inhibited inflammation and prevented loss of retinal ganglion cells. Using Boyden’s chamber assay we found that BBI inhibited invasiveness of activated splenocytes through the matrigel barrier. These results indicate that BBI is an excellent candidate for oral therapy in multiple sclerosis.
APA, Harvard, Vancouver, ISO, and other styles
46

An, Xiaoming, Takeshi Kezuka, Yoshihiko Usui, Yoshimichi Matsunaga, Ryusaku Matsuda, Naoyuki Yamakawa, and Hiroshi Goto. "Suppression of Experimental Autoimmune Optic Neuritis by the Novel Agent Fingolimod." Journal of Neuro-Ophthalmology 33, no. 2 (June 2013): 143–48. http://dx.doi.org/10.1097/wno.0b013e31828ea2fc.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Zhang, Hongliang, Xu Wang, and Jie Zhu. "Neuritogenic Th17 cells in Guillain–Barré syndrome and experimental autoimmune neuritis." Journal of Neuroimmunology 275, no. 1-2 (October 2014): 74–75. http://dx.doi.org/10.1016/j.jneuroim.2014.08.196.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Hagiwara, Wataru, Masashi Inoue, Shingo Konno, and Toshiki Fujioka. "The effects of cilostazol on experimental autoimmune neuritis in Lewis rats." Journal of Neuroimmunology 275, no. 1-2 (October 2014): 116–17. http://dx.doi.org/10.1016/j.jneuroim.2014.08.310.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Herold, Sabine, Prateek Kumar, Sven Wichert, Mathias Baehr, Moritz Rossner, and Katharina Hein. "Gene expression analysis of retinal neurons in experimental autoimmune optic neuritis." Journal of Neuroimmunology 275, no. 1-2 (October 2014): 125. http://dx.doi.org/10.1016/j.jneuroim.2014.08.334.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Jung, Stefan, Stefanie Gaupp, Hans-Peter Hartung, and Klaus V. Toyka. "Oral tolerance in experimental autoimmune neuritis (EAN) of the Lewis rat." Journal of Neuroimmunology 116, no. 1 (May 2001): 21–28. http://dx.doi.org/10.1016/s0165-5728(01)00276-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Experimental Autoimmune Neuritis' for other source types:
Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography